Bicycle Therapeutics PLC (NASDAQ:BCYC)
| 15.81 Delayed Data As of Dec 08 |  +0.10 / +0.64%Today’s Change | 12.54 Today|||52-Week Range 33.49 | -46.59% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 4 2017 | Quarter 1 2018 | Quarter 4 2018 | Quarter 1 2019 | |||
| Operating Activities | Net Income / Starting Line | -- | -2.6M | -- | -6.6M | |
| Depreciation | -- | 167.1K | -- | 215.3K | ||
| Total Other Cash Flow | -- | 291.9K | -- | 3.5M | ||
| Funds From Operations | -- | -2.1M | -- | -2.8M | ||
| Funds From/For Other Operating Expenses | -- | 5.2M | -- | 2.2M | ||
| Net Cash Flow - Operating Activities | -- | -7.3M | -- | -5.1M | ||
| Investing | Capital Expenditures | -- | -265.8K | -- | -422.4K | |
| Net Cash Flow Investing | -- | -265.8K | -- | -422.4K | ||
| Financing | Short Term Borrowings | -- | 0.00 | -- | -177.9K | |
| Long Term Borrowings | -- | 0.00 | -- | 0.00 | -- | |
| Long Term Debt Reduction | -- | 0.00 | -- | 0.00 | -- | |
| Net Proceeds Stock Sale | -- | 0.00 | -- | 34.4K | ||
| Common Preferred Redeemed | -- | 0.00 | -- | 0.00 | -- | |
| Common Dividends | -- | -- | -- | -- | -- | |
| Cash Dividends Paid - Total | -- | 0.00 | -- | 0.00 | -- | |
| Other Sources - Financing | -- | 0.00 | -- | 0.00 | -- | |
| Other Uses - Financing | -- | 0.00 | -- | 0.00 | -- | |
| Net Cash Flow - Financing | -- | 0.00 | -- | -143.5K | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | 2.4M | -- | 1.6M | |
| Net Change In Cash | 0.00 | -7.6M | 0.00 | -5.6M | ||
